A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST
Clinical trial NCT04530981 · COMPLETED
Trial details
- NCT number
- NCT04530981
- Sponsor
- Deciphera Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2023-11-16
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.